Want to join the conversation?
$CI's revenue from premiums for 4Q15 increased to $7.46Bil from $6.91Bil last year and that from fees grew to $1.06Bil from $1.02Bil. Net investment income slid to $295MM from $303MM, while mail order pharmacy revenue grew to $690MM from $614MM. Other revenue rose to $73MM from $60MM.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.